Phase 3 Moderate-to-severe Atopic Dermatitis trials recruiting now

All Moderate-to-severe Atopic Dermatitis trials, every phase

Phase 3 Moderate-to-severe Atopic Dermatitis trials

• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
  NCT07711418 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 13 locations
• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
  NCT07690371 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 19 locations
• Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
  NCT06239311 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis
  NCT07370909 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
  NCT06723080 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.